ANCOR is pleased to have Greenwich Biosciences as a Platinum Partner
Greenwich Biosciences, based in Carlsbad, CA, is a focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform.
With nearly two decades of investment and research, Greenwich Biosciences is at the forefront of cannabinoid science. The company's aim is to unlock the potential of cannabinoid prescription medicines to address serious conditions that currently have limited, or non-existent, treatment options. A result of this work has been Greenwich Biosciences becoming the first — and currently only — company to receive FDA approval for a plant-derived cannabinoid therapy that addresses difficult to treat conditions with unmet needs.
National Account Executive
(321) 217 -1158 (cell)